- Home
- / M2I Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
M2I Life Sciences financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
€6.9 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2021 |
|---|---|
| Revenue | 6.9M |
| Cost of goods sold | 25.0 |
| Gross profit | 6.9M |
| Gross profit margin, % | 100.0% |
| General and administrative expense | 3.1M |
| Operating expense total | 8.4M |
| Depreciation and amortization | 483.2K |
| EBIT | 1.2M |
| EBIT margin, % | 17.1% |
| Interest income | 86.8K |
| Interest expense | 707.4K |
| Pre tax profit | 560.5K |
| Income tax expense | (440.2K) |
| Net Income | 889.0K |